Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Another Beautifully Bogus Press release from 3/27/15. Cells are all ready and Clinical Trails are set to commence. LOL and 4 years later some still believe this is a real company.
PharmaCyte Biotech on Track to Commence Clinical Trials
SILVER SPRING, Md., March 27, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that the genetically modified cells that are required for its three planned clinical trials have been fully tested and are in the process of being propagated to produce all of the cells necessary for the clinical trials.
The cells being produced came from a fully characterized single-cell clone of the cells that were used in the previous clinical trials in pancreatic cancer. These cells are being grown under conditions that comply with current Good Manufacturing Practices (cGMP) standards.
One of PharmaCyte Biotech's clinical trials consists of a Phase 2b trial where PharmaCyte Biotech's pancreatic cancer treatment will be compared "head-to-head" with the best available chemotherapy (Abraxane® plus gemcitabine) for advanced pancreatic cancer. The Phase 2b clinical trial will be conducted in Australia by Clinical Network Services (CNS). PharmaCyte Biotech's pancreatic cancer treatment consists of encapsulating the genetically modified cells, using the Cell-in-a-Box® live cell encapsulation technology, and placing the capsules with the live cells inside them near the site of the cancerous tumor. The patient is then given an inactive cancer drug, ifosfamide, intravenously at one-third the normal dose. When the blood carrying the ifosfamide comes in contact with the encapsulated cells the ifosfamide is converted into its cancer-killing form.
Two additional clinical trials will be conducted in the U.S. by Translational Drug Development (TD2). These trials will determine the effectiveness of PharmaCyte Biotech's treatment in (i) reducing the severe pain that occurs in patients with advanced pancreatic cancer; and (ii) slowing the accumulation of malignant fluid (ascites) that accompanies the development of pancreatic and other solid cancerous tumors in the abdomen.
Kenneth L. Waggoner, the Chief Executive Officer of PharmaCyte Biotech, stated, "We are very pleased that work being done to grow the cells required for our clinical trials has proceeded according to our plans. Together with our partner, Austrianova, we are complying with all current regulatory guidelines to ensure that these cells will be made available to us as quickly as possible so we can commence our clinical trials in a timely fashion."
Read the many Bogus Press releases PharmaCyte has issued over the past 6 years including this beauty from January 04, 2016.
PharmaCyte Biotech Outlines 2016 Milestones as Its Pancreatic Cancer Treatment Moves Into a Clinical Trial
https://ir.pharmacytebiotech.com/press-releases/detail/77/pharmacyte-biotech-outlines-2016-milestones-as-its
Link to all the Bogus Press Releases through the years. Note that the company has stopped issuing Written shareholder updates on the date of the above release so that their Bogus words are no longer searchable (The Shady One is Cleaver)
https://ir.pharmacytebiotech.com/press-releases
Just keep listening to the 15 Year longs because they have been spot on for a decade and a half about all things Nuvilex and PMCB. LMFAO.
I will gladly send you the email from IR. You can send the original email to IR and ask them if i doctored it and they can take legal action. You will to do the same with yours? Fact is many here just want to believe PMCB is a real company and anything that shows how hack they are can't be real.
Again where are the details of this collaboration? They won what $5k and where is the deal? When can i start getting bacteria beads in my shampoo?
Did they? And what were the details of this partnership? CIAB shampoo?
Linking Austrianova's website is proving my point. Please anyone looking to invest in PMCB go to Austrianova's website that looks like it hasn't been updated since 1990. The last press release is 3 years old. WOW exciting times!!! Oh ya and they have a whopping 280 facebook followers. Double WOW!!!!
Obviously the company has no IR department. Whoever is responding to shareholders is just part of the say anything to convince the believers that PMCB is working itself to death trying to file their IND. Meanwhile Shady Kenny has openly stated "we are just waiting on vendors" and "its not in our control". What exactly is the great management (KW,Crabtree and Carlos) of PMCB doing 24/7? Anyone still wondering why no Institutional interest, no partnerships, no progress? What you have here is a company that has been in business for over two decades now on its third "business model" and having produced nothing. A company that only releases Puff paid for PR's only when its "3rd Party" that buys shares at .01 needs to unload their shares at 300-400% profit and then start the cycle all over again. Any objective person can clearly see this is a stock selling scam run by a known stock selling scammer. IMHO
The email is true. If you choose to believe that last paragraph about Management working non-stop 365 days a year then I find that sad. What kind of a company would hire an IR staff that would write this kind of response? Can you imagine any real company replying this way? Trying desperately to pull at the heart of an investor. Its ridicules. IMHO
Shady Kenny has the best tan I have ever seen 365 days a year.
Believe me or not it is exactly what I sent and what was received back from IR. I will forward it to you if you would like. I have nothing to hide.
Don't really care if you believe it but it is not a fake.
The response. This is LOL Hysterical that IR would make these claims. I laughed for several min.
Dear
We did not receive an email from you last week.
We do not monitor or even look at message boards.
Everyone at PharmaCyte is working diligently to bring PharmaCyte’s therapy for pancreatic cancer to the point of an IND submission to the FDA. Obviously you do not understand what it takes to successfully develop an encapsulated live-cell based therapy. Given the complexity of PharmaCyte’s therapy, it would be speculative to predict when the next update will occur. The update will likely be in the form of a press release, as has been our practice in the past.
You claim that management has not shown loyalty to its shareholders. Nothing could be further from the truth. Since 2014 management has worked 7 days a week in support of this company. Management foregoes holidays, vacations and time with their families. The health of every person in management has suffered as a result of his work schedule – one person to the extreme.
Investor Relations
23046 Avenida de la Carlota, Suite 600
Laguna Hills, California 92630
O 917.595.2856 | F 917.595.2851
cid:image002.png@01D0923A.9ECCBA40
Of course I will share just funning. Here is my message to IR. I may have embellished a bit.
To whom it may concern:
Last week I emailed about my concern of the lack of updates PharmaCyte provides to its loyal shareholders. Today I am writing to inform you that I will no longer be a loyal shareholder by week end if you as a company cannot find a few minutes in your day to update me. I will not speak for any other shareholder but I know that you as a company monitor message boards and realize many are very upset. PharmaCyte has been given many years by its shareholders to advance their technology and many have held or added to their position in full support yet the management of your company has not shown loyalty in return. For me this week will be the end of my loyalty if the company continues to remain silent. No one is asking for firm deadlines or privileged information just a little respect.
I received a response from IR. I would share but I owe no one here anything.
If PMCB told you what was "going on" at any point in the past 6 years this stock would be sub-penny. Because obviously nothing is going on. Clinical stage Biotech's spend enormous amounts of money on R&D yet PMCB spends practically nothing. The only R&D expenses PMCB seems to have are the payouts to Austrianova to keep them afloat. Anyone here that thinks that all of these great medical people spend one minute a day working on PMCB related are just blinded by fantasy $$ signs and not reality. If you havn't figured it out by now PMCB is a stock selling scam it always has been (Nuvilex,Efood Saftey). Only in business to issue fluff PR's and sell shares. IMHO
2011 was the first mention of Clinical Trials. If anyone reading this actually thinks it takes 8 years to produce the required reports and testing to file an Ind for a modified cell line wrapped in a cotton cocoon then Biotech is not your thing.
The last PR was a paid for pump by a 3rd party.
Last PR was a paid for 3rd party pump so the .01 shares sold to whoever could unload them. Since when does a real company give access to its Employee's and Consultants to paid for stock promotions? That should tell everyone something about this company. IMHO
They probably have a gag order on announcing there is a gag order in place. LOL
Shady Kenny has plenty of Gold Teeth.
And the predictor suddenly quiet. It is comical how people post that they want to know whats going on. CALL THE COMPANY AND DEMAND TO KNOW. No answer? KEEP CALLING ITS YOUR MONEY. What are they going to do take your shares away?
Back to fantasizing about $25 PPS. Ignore the facts that PharmaCyte is a company that has pumping clinical trials soon for eight years. Forget about the fact PharmaCyte has no cash on hand to even file an IND. Who cares that PharmaCyte has spent money only on paying it 71 year old penny stock Lawyer and retired pushing 80 year old COO. Pay no attention to the TOTAL lack of interest of Institutional Investors and any other Biotech ever in Pharmacyte or its technology. Filing their fantasy IND will turn this do nothing fake company from a 50 Million market cap to 25 Billion overnight.
OK the fairy tale is through for today back to reality. PharmaCyte is and always has been a company in business to sell dreams and shares only to pay its fraud management. Just do 10 min of research and you will come to that conclusion. IMHO
Eight years of claiming Clinical Trials Soon. Eight years of NOTHING.
Nuvilex, Inc. Readies Pancreatic Cancer Treatment for Expanded Phase II Clinical Trials
Jun 6, 2011 10:22am
SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Nuvilex, Inc. (OTCQB: NVLX) announced today it is aggressively engaging the steps necessary to use its encapsulated cell technology for pancreatic cancer in expanded Phase II clinical trials in the United States, Europe and Australia. The Company’s objective is to have a protocol submitted to the regulatory agencies in these countries as quickly as possible.
In conjunction with SG Austria, the world’s leading cell encapsulation technology company based in Singapore, Nuvilex has already activated our plan for rapid entry into expanded pancreatic cancer clinical trials. Necessary funding to initiate this phase of the study has been secured and the principals from both companies are working in close harmony to develop, implement, and oversee plans for the new clinical trials.
BTW thats where Mr. Carlos A. Trujillo the current CFO & Director at PMCB came from also.
Mr. Trujillo previously was Chief Financial Officer of California Cove Communities, Inc., Chief Financial & Accounting Officer of VelaTel Global Communications, Inc.
Really? You mean a cure for cancer with no side effects being developed by a penny stock company with no Biotech experience and no money or ability to raise money wasn't believable? Who would have thunk. We all learn lessons the hard way. IMHO
Who cares about Canine trials. Every treatment ever brought to trial has had great animal testing results. And on top of that it was for a completely different type of Cancer.
No IND Submission No Partnership No Buyout. Just a company with 3 employees none of which are doing much of anything. Shady Kenny even admitted years ago that PMCB has nothing to do but wait on vendors. Yet Financial reports show he is spending next to nothing on R&D including vendors. Time will eventually show that nothing has been going on other then cashing massive paychecks. IMHO
•Eliminates the need for anti-rejection medication. Read slide 12
The slides were a little more convincing then a Kenny PR. LOL
Potential New Investors please use the link below to read the Press Releases from this company the past five years. PMCB has been Promising Clinical Trials Soon for over five years now. Yet their quarterly reports show almost no spending on R&D. Do your Due Diligence on this company that was also Called Nuvilex and efood saftey.
https://pharmacyte.com/news/
An experienced biotech CEO would have had this to trials 2 years ago.
No actually 5 years ago. What has Shady Kenny done to improve CIAB? He has spent almost no money on R&D.
LOL. The CRO is a mess but PMCB is legit. That is believable only here.
5 Years ago was the fake run to the .40's and here PMCB is down over 90% and twice the number of shares. What has Shady Kenny accomplished in those 5 years?
He now has several more Millions of $ in his retirement account.
Anything else?
Ind?
Pre-clinical study results?
Clinical trials?
Partnerships?
Anything?????
Seems most people left here owned this stock before Shady Kenny arrived so why should anyone listen to predictions from people that bought into a scam natural cancer cure/tattoo ink company. Nuvilex was a classic scam company and now its a classic scam biotech company. IMHO
How did the shareholders meeting go the IR promised? How have the CC's quarterly gone? How has Kenny protecting shareholder value gone?
Prediction. Next PR will be a announcement of a Kenny Shareholder Call. Fits his profile of delivering news of delays and excuses. IMHO
Don't you understand the "new" storyline is CIAB for PC is only going to happen as a proving ground for all of the other CIAB cures. Meanwhile many new treatments and approaches thankfully are making their way through trials because I think most know PMCB is all about style and nothing about substance. IMHO
New Pancreatic Cancer Therapies Extending Lives
https://www.webmd.com/cancer/pancreatic-cancer/news/20190402/new-pancreatic-cancer-therapies-extending-life#1
Strange how PMCB did not issue a congrats to Dr. Manuel Hidalgo on his Job. Could he be the latest to dump PMCB? Also seem Dr Hidalgo has found a new mate.
Mar 21, 2019, 09:00 ET
Agenus Announces Clinical Appointments
- Dr. Manuel Hidalgo, MD, PhD as Strategic Advisor
https://www.prnewswire.com/news-releases/agenus-announces-clinical-appointments-300816271.html
Those who make predictions here have never been right yet year after year it continues. PMCB has no partners, no source of funding other then selling blocks of shares at 75% discount. PMCB has 3 real employees a 70 year old lawyer a 80 year old doctor that hasn't been involved in clinical research for decades and a CPA. All of the other names they like to drop in PR's are paid consultants that work real full time plus jobs not PMCB related. PMCB has no physical location other then shared office space near KW's home and no one knows if they even use it. PMCB has less then 1 million cash on hand not even enough to file an IND never mind the $15 million their own clueless CEO admits it will take to conduct a Clinical Trial. PMCB has been saying they are going to conduct a Clinical Trial every year going on 6 years now. Buyer BEWARE do your Due Diligence on PMCB and its former name Nuvilex. IMHO